Literature DB >> 31127615

Aquaporin 4: A key player in Parkinson's disease.

Omid Reza Tamtaji1, Mohammad Behnam2, Mohammad Ali Pourattar3, Hamed Jafarpour4, Zatollah Asemi1.   

Abstract

Parkinson's disease (PD) is one of the most prevalent neurodegenerative diseases which occur in aged people worldwide. Given that a sequence of cellular and molecular mechanisms, including oxidative stresses, apoptosis, inflammatory pathways, microglia, astrocyte activation, and aquaporin 4 (AQP4) are associated with initiation and the progression of PD. AQP4 may affect various pathways (i.e., α-synuclein, inflammatory pathways, and microglia and astrocyte activation). Few reports have evaluated the relationship between AQP4 and PD-related cellular and molecular pathways. Here, for the first time, we highlighted the relationship between AQP4 and molecular mechanisms involved in PD pathogenesis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson disease; aquaporin 4; astrocyte; microglia; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31127615     DOI: 10.1002/jcp.28871

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 2.  The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy.

Authors:  Mohammad Behnam; Alireza Motamedzadeh; Marzieh Aalinezhad; Ehsan Dadgostar; Fatemeh Zahra Rashidi Noshabad; Mohammad Pourfridoni; Maedeh Raei; Hamed Mirzaei; Michael Aschner; Omid Reza Tamtaji
Journal:  Mol Biol Rep       Date:  2022-06-17       Impact factor: 2.316

Review 3.  Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target.

Authors:  Ehsan Dadgostar; Shiva Rahimi; Shahin Nikmanzar; Sina Nazemi; Mojtaba Naderi Taheri; Zahra Alibolandi; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurochem Res       Date:  2022-01-28       Impact factor: 3.996

4.  Polymorphisms in the Human Aquaporin 4 Gene Are Associated With Schizophrenia in the Southern Chinese Han Population: A Case-Control Study.

Authors:  Yung-Fu Wu; Huey-Kang Sytwu; For-Wey Lung
Journal:  Front Psychiatry       Date:  2020-06-26       Impact factor: 4.157

Review 5.  Probiotics and the Treatment of Parkinson's Disease: An Update.

Authors:  Hamed Mirzaei; Saman Sedighi; Ebrahim Kouchaki; Erfaneh Barati; Ehsan Dadgostar; Michael Aschner; Omid Reza Tamtaji
Journal:  Cell Mol Neurobiol       Date:  2021-07-20       Impact factor: 4.231

Review 6.  Neuron-Astrocyte Interactions in Parkinson's Disease.

Authors:  Ikuko Miyazaki; Masato Asanuma
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

7.  Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.

Authors:  Jing Wang; Ruihua Cao; Tao Huang; Cheng Liu; Yidong Fan
Journal:  Parkinsons Dis       Date:  2020-11-28

Review 8.  Aquaporins in insulin resistance and diabetes: More than channels!

Authors:  Mauro Galli; Ahsan Hameed; Arkadiusz Żbikowski; Piotr Zabielski
Journal:  Redox Biol       Date:  2021-05-27       Impact factor: 11.799

Review 9.  Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles.

Authors:  Ehsan Dadgostar; Vida Tajiknia; Negar Shamsaki; Mojtaba Naderi-Taheri; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  EXCLI J       Date:  2021-06-01       Impact factor: 4.068

10.  Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease.

Authors:  Shanshan Hu; Meigui Hu; Jian Liu; Bei Zhang; Zhen Zhang; Fiona H Zhou; Liping Wang; Jianghui Dong
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-04       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.